Remedent 

$0.000700
2
-$0.00-0% Monday 13:30

Statistics

Day High
0.0007
Day Low
0.0002
52W High
0.01
52W Low
0.0002
Volume
7,000
Avg. Volume
-
Mkt Cap
13,997.2
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.02
-0.01
-0
0
Expected EPS
0
Actual EPS
-0.0175

Financials

-27.79%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
1.97MRevenue
-548,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow REMI. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Remedent, Inc., operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers. Its innovative product portfolio features River8, a pre-fabricated veneer solution that assists dentists in achieving optimal tooth alignment with minimal patient tooth reshaping. Additionally, Remedent supplies GlamSmile veneers, which are exceptionally thin shells bonded to the front surfaces of a patient's teeth. Beyond physical products, the company offers a suite of digital tools and services aimed at enhancing dental practice operations. These include the SmileMe Mirror, an integrated marketing concept that enables quick smile consultations in about ten minutes; SmileSketch, simulation software capable of creating visual previews of potential aesthetic results; and various "Treatment Pages" designed to explain the advantages of specific dental procedures. Furthermore, Remedent provides the Condor, an advanced intra-oral 3D scanning device. The company's expertise also extends to dental implant technologies and related treatment methodologies. Remedent distributes its products to dental professionals in nearly 30 countries, spanning regions such as Asia, Europe, the Middle East, Canada, and the United States, utilizing both its internal sales team and third-party distributors. Founded in 1986, the company's corporate headquarters are located in Ghent, Belgium.
Show more...
CEO
Mr. Guy De Vreese
Employees
3
Country
United States
ISIN
US75954T1043

Listings

0 Comments

Share your thoughts

FAQ

What is Remedent stock price today?
The current price of REMI is $0.00 USD — it has decreased by -0% in the past 24 hours. Watch Remedent stock price performance more closely on the chart.
What is Remedent stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Remedent stocks are traded under the ticker REMI.
Is Remedent stock price growing?
REMI stock has fallen by -0% compared to the previous week, the month change is a -0% fall, over the last year Remedent has showed a -93% decrease.
What is Remedent market cap?
Today Remedent has the market capitalization of 13,997.2
What were Remedent earnings last quarter?
REMI earnings for the last quarter are -0.02 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Remedent revenue for the last year?
Remedent revenue for the last year amounts to 1.97M USD.
What is Remedent net income for the last year?
REMI net income for the last year is -548,000 USD.
How many employees does Remedent have?
As of June 16, 2026, the company has 3 employees.
In which sector is Remedent located?
Remedent operates in the Health & Wellness sector.
When did Remedent complete a stock split?
Remedent has not had any recent stock splits.
Where is Remedent headquartered?
Remedent is headquartered in Gent, United States.